相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
V. A. Simonovich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
Divyanshu Dubey et al.
ANNALS OF NEUROLOGY (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan A Retrospective Observational Study
Yingzhen Du et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019
Shaobo Shi et al.
EUROPEAN HEART JOURNAL (2020)
Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series
Negar Mohtadi et al.
VIROLOGY (2020)
Covid-19: WHO declares pandemic because of alarming levels of spread, severity, and inaction
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2020)
Therapeutic strategies for critically ill patients with COVID-19
Lei Li et al.
ANNALS OF INTENSIVE CARE (2020)
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
Wei Cao et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study
Jiao Liu et al.
ANNALS OF INTENSIVE CARE (2020)
Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China
You Shang et al.
ANNALS OF INTENSIVE CARE (2020)
Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis
Axel Nierhaus et al.
ANNALS OF INTENSIVE CARE (2020)
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019
Shaobo Shi et al.
EUROPEAN HEART JOURNAL (2020)
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
Richard T. Davey et al.
LANCET RESPIRATORY MEDICINE (2019)
Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock
Yusuke Iizuka et al.
CRITICAL CARE (2017)
Immunosuppressive Therapy in Transplantation
Terri L. Allison
NURSING CLINICS OF NORTH AMERICA (2016)
Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia
Yaseen M. Arabi et al.
EMERGING INFECTIOUS DISEASES (2016)
Intravenous Immunoglobulin and Mortality in Pneumonia Patients With Septic Shock: An Observational Nationwide Study
Takashi Tagami et al.
CLINICAL INFECTIOUS DISEASES (2015)
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Inessa Schwab et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective
Manu Shankar-Hari et al.
CRITICAL CARE (2012)
Guidelines for the diagnosis and management of disseminated intravascular coagulation
M. Levi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Modulation of the cellular immune system by intravenous immunoglobulin
Thanyalak Tha-In et al.
TRENDS IN IMMUNOLOGY (2008)
Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery
A Rodríguez et al.
SHOCK (2005)
Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients
JT Wang et al.
EMERGING INFECTIOUS DISEASES (2004)
Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome:: A European randomized, double-blind, placebo-controlled trial
J Darenberg et al.
CLINICAL INFECTIOUS DISEASES (2003)